| Year |
Citation |
Score |
| 2018 |
Liu X, Li M, Smyth H, Zhang F. Otic Drug Delivery Systems: Formulation Principles and Recent Developments. Drug Development and Industrial Pharmacy. 1-41. PMID 29659300 DOI: 10.1080/03639045.2018.1464022 |
0.324 |
|
| 2017 |
Hua X, Yang Q, Dong Z, Zhang J, Zhang W, Wang Q, Tan S, Smyth HD. Magnetically triggered drug release from nanoparticles and its applications in anti-tumor treatment. Drug Delivery. 24: 511-518. PMID 28181827 DOI: 10.1080/10717544.2016.1256001 |
0.322 |
|
| 2017 |
Du P, Du J, Smyth HD. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading. Journal of Pharmaceutical Sciences. 106: 366-376. PMID 27939234 DOI: 10.1016/J.Xphs.2016.09.035 |
0.405 |
|
| 2017 |
Yazdi AK, Smyth HD. Implementation of design of experiments approach for the micronization of a drug with a high brittle-ductile transition particle diameter. Drug Development and Industrial Pharmacy. 43: 364-371. PMID 27788610 DOI: 10.1080/03639045.2016.1253727 |
0.344 |
|
| 2016 |
Gadok AK, Busch DJ, Ferrati S, Li B, Smyth HD, Stachowiak JC. Connectosomes for Direct Molecular Delivery to the Cellular Cytoplasm. Journal of the American Chemical Society. PMID 27607109 DOI: 10.1021/Jacs.6B05191 |
0.339 |
|
| 2016 |
Yazdi AK, Smyth HD. Carrier-free high-dose dry powder inhaler formulation of ibuprofen: Physicochemical characterization and in vitro aerodynamic performance. International Journal of Pharmaceutics. PMID 27349791 DOI: 10.1016/J.Ijpharm.2016.06.061 |
0.399 |
|
| 2016 |
Chattopadhyay S, Smyth H, Biswas P. Editorial: Pulmonary Delivery of Systemic Drugs- from Aerosol Generation to Efficacious Delivery. Current Pharmaceutical Design. PMID 26996783 DOI: 10.2174/1381612822999160321124803 |
0.346 |
|
| 2016 |
Yazdi AK, Smyth HD. Hollow crystalline straws of diclofenac for high-dose and carrier-free dry powder inhaler formulations. International Journal of Pharmaceutics. 502: 170-180. PMID 26911418 DOI: 10.1016/J.Ijpharm.2016.02.030 |
0.404 |
|
| 2016 |
Smyth HD. Recent advances in solid dispersions and the formulation of poorly absorbed drugs. Drug Development and Industrial Pharmacy. 42: 351-2. PMID 26824575 DOI: 10.3109/03639045.2016.1147716 |
0.328 |
|
| 2015 |
Thakkar SG, Fathe K, Smyth HD. Amorphous or crystalline? A comparison of particle engineering methods and selection. Current Pharmaceutical Design. PMID 26446464 DOI: 10.2174/1381612821666151008150457 |
0.331 |
|
| 2014 |
Hua X, Tan S, Bandara HM, Fu Y, Liu S, Smyth HD. Externally controlled triggered-release of drug from PLGA micro and nanoparticles. Plos One. 9: e114271. PMID 25479357 DOI: 10.1371/Journal.Pone.0114271 |
0.345 |
|
| 2014 |
Du J, El-Sherbiny IM, Smyth HD. Swellable ciprofloxacin-loaded nano-in-micro hydrogel particles for local lung drug delivery. Aaps Pharmscitech. 15: 1535-44. PMID 25079240 DOI: 10.1208/s12249-014-0176-x |
0.364 |
|
| 2014 |
Du P, Du J, Smyth HD. Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size. Aaps Pharmscitech. 15: 1417-28. PMID 24962007 DOI: 10.1208/S12249-014-0166-Z |
0.439 |
|
| 2013 |
Du J, Du P, Smyth HD. Hydrogels for controlled pulmonary delivery. Therapeutic Delivery. 4: 1293-305. PMID 24116913 DOI: 10.4155/Tde.13.90 |
0.34 |
|
| 2013 |
Guzman-Villanueva D, El-Sherbiny IM, Herrera-Ruiz D, Smyth HD. Design and in vitro evaluation of a new nano-microparticulate system for enhanced aqueous-phase solubility of curcumin. Biomed Research International. 2013: 724763. PMID 23984402 DOI: 10.1155/2013/724763 |
0.404 |
|
| 2013 |
Saleem IY, Smyth HD. Tuning aerosol particle size distribution of metered dose inhalers using cosolvents and surfactants. Biomed Research International. 2013: 574310. PMID 23984381 DOI: 10.1155/2013/574310 |
0.599 |
|
| 2012 |
Beinborn NA, Du J, Wiederhold NP, Smyth HD, Williams RO. Dry powder insufflation of crystalline and amorphous voriconazole formulations produced by thin film freezing to mice. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 81: 600-8. PMID 22569473 DOI: 10.1016/J.Ejpb.2012.04.019 |
0.34 |
|
| 2012 |
El-Sherbiny IM, Smyth HD. Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles. Molecular Pharmaceutics. 9: 269-80. PMID 22136259 DOI: 10.1021/mp200351y |
0.365 |
|
| 2012 |
Donovan MJ, Kim SH, Raman V, Smyth HD. Dry powder inhaler device influence on carrier particle performance. Journal of Pharmaceutical Sciences. 101: 1097-107. PMID 22095397 DOI: 10.1002/Jps.22824 |
0.377 |
|
| 2011 |
Guzman-Villanueva D, Smyth HD, Herrera-Ruiz D, El-Sherbiny IM. A Novel Aerosol Method for the Production of Hydrogel Particles. Journal of Nanomaterials. 2011. PMID 23687513 DOI: 10.1155/2011/507508 |
0.444 |
|
| 2011 |
Donovan MJ, Gibbons A, Herpin MJ, Marek S, McGill SL, Smyth HD. Novel dry powder inhaler particle-dispersion systems. Therapeutic Delivery. 2: 1295-311. PMID 22826884 DOI: 10.4155/Tde.11.103 |
0.329 |
|
| 2011 |
El-Sherbiny IM, Smyth HD. Smart Magnetically Responsive Hydrogel Nanoparticles Prepared by a Novel Aerosol-Assisted Method for Biomedical and Drug Delivery Applications. Journal of Nanomaterials. 2011: 1-13. PMID 21808638 DOI: 10.1155/2011/910539 |
0.386 |
|
| 2011 |
Marek SR, Donovan MJ, Smyth HD. Effects of mild processing pressures on the performance of dry powder inhaler formulations for inhalation therapy. 1: Budesonide and lactose. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 78: 97-106. PMID 21182942 DOI: 10.1016/J.Ejpb.2010.12.020 |
0.421 |
|
| 2011 |
Selvam P, El-Sherbiny IM, Smyth HD. Swellable hydrogel particles for controlled release pulmonary administration using propellant-driven metered dose inhalers. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 24: 25-34. PMID 20961166 DOI: 10.1089/Jamp.2010.0830 |
0.46 |
|
| 2010 |
Saleem IY, Smyth HD. Micronization of a soft material: air-jet and micro-ball milling. Aaps Pharmscitech. 11: 1642-9. PMID 21107775 DOI: 10.1208/S12249-010-9542-5 |
0.607 |
|
| 2010 |
McGill SL, Smyth HD. Disruption of the mucus barrier by topically applied exogenous particles. Molecular Pharmaceutics. 7: 2280-8. PMID 20919744 DOI: 10.1021/mp100242r |
0.36 |
|
| 2010 |
Donovan MJ, Smyth HD. Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations. International Journal of Pharmaceutics. 402: 1-9. PMID 20816928 DOI: 10.1016/j.ijpharm.2010.08.045 |
0.378 |
|
| 2010 |
El-Sherbiny IM, Smyth HD. Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery: (I) self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheres. International Journal of Pharmaceutics. 395: 132-41. PMID 20580794 DOI: 10.1016/j.ijpharm.2010.05.032 |
0.308 |
|
| 2010 |
El-Sherbiny IM, McGill S, Smyth HD. Swellable microparticles as carriers for sustained pulmonary drug delivery. Journal of Pharmaceutical Sciences. 99: 2343-56. PMID 19967777 DOI: 10.1002/jps.22003 |
0.35 |
|
| 2008 |
Saleem I, Smyth H, Telko M. Prediction of dry powder inhaler formulation performance from surface energetics and blending dynamics. Drug Development and Industrial Pharmacy. 34: 1002-10. PMID 18686090 DOI: 10.1080/03639040802154905 |
0.575 |
|
| 2007 |
Hickey AJ, Mansour HM, Telko MJ, Xu Z, Smyth HD, Mulder T, McLean R, Langridge J, Papadopoulos D. Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics. Journal of Pharmaceutical Sciences. 96: 1302-19. PMID 17455364 DOI: 10.1002/Jps.20943 |
0.356 |
|
| 2007 |
Hickey AJ, Mansour HM, Telko MJ, Xu Z, Smyth HD, Mulder T, McLean R, Langridge J, Papadopoulos D. Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics. Journal of Pharmaceutical Sciences. 96: 1282-301. PMID 17455324 DOI: 10.1002/Jps.20916 |
0.319 |
|
| 2006 |
Smyth H, Hickey AJ, Brace G, Barbour T, Gallion J, Grove J. Spray pattern analysis for metered dose inhalers I: Orifice size, particle size, and droplet motion correlations. Drug Development and Industrial Pharmacy. 32: 1033-41. PMID 17012116 DOI: 10.1080/03639040600637598 |
0.304 |
|
| 2004 |
Smyth HD, Beck VP, Williams D, Hickey AJ. The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers. Aaps Pharmscitech. 5: E7. PMID 15198528 DOI: 10.1208/Pt050107 |
0.336 |
|
| 2003 |
Smyth HD, Hickey AJ. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers. Aaps Pharmscitech. 4: E38. PMID 14621970 DOI: 10.1208/pt040338 |
0.334 |
|
| Show low-probability matches. |
